Speaker Profile
CFO, MegAITex
Biography
Seasoned executive and board advisor with over 20 years of leadership experience in governance, risk, compliance (GRC), cybersecurity, and AI-driven digital resilience.Has a proven track record of guiding global enterprises and fintech startups through complex regulatory landscapes, technology transformation, and operational scaling.Successfully built and scaled multimillion-dollar GRC practices, launched award-winning Financial products, and pioneered AI-based compliance solutions in collaboration with industry leaders like Google and Microsoft.
Talk
Diagnosis of Low-Grade Central Osteosarcoma
This presentation showcases a clinical case of low-grade central osteosarcoma often misdiagnosed as fibrous dysplasia. Using a ResNet-101 convolutional neural network for automated mitosis detection, AI accurately identified malignancy (up to 99% probability), aligning with expert diagnoses. The study highlights AIs promise to improve accuracy, reproducibility, and confidence in complex pathology.
AI and Data Sciences Showcase:
MegAITex
MegAITex is an AI-driven medical technology company developing deep learning solutions to enhance diagnostic accuracy and efficiency in pathology. Its platform leverages advanced neural networks to detect early signs of cancer and other diseases from digitized biopsy images, reducing diagnostic errors and enabling faster, more reliable clinical decisions.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 AI Company Showcase will provide a 15-30 minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
